Schrodinger Inc (SDGR)

Sep 23, 2026

This article provides a precision trading analysis for Schrodinger Inc. (SDGR), highlighting its strong near and mid-term sentiment and upside potential. It outlines specific institutional trading strategies including position, momentum breakout, and risk hedging, complete with entry zones, targets, and stop losses. The analysis also details multi-timeframe signal strengths and support/resistance levels generated by AI models.

Sep 19, 2026

Schrodinger Inc (SDGR) shares recently dropped 4.0% to $29.01, and GuruFocus's GF Value estimates the stock is 17.5% overvalued at $24.69. The company has a GF Score of 70/100, indicating above-average quality, but struggles with profitability and has seen significant insider selling without any buying activity. Investors are cautioned due to the overvaluation, weak profitability, and lack of insider confidence.

Sep 17, 2026

Schrödinger's (SDGR) stock surged approximately 60% this week, climbing above $30, despite underlying concerns about slowing software metrics and a reduced drug pipeline. The company's software business shows signs of deterioration, and its drug development strategy has become more cautious, relying on partnerships. While the balance sheet has improved, the rally faces significant challenges from mixed fundamentals and execution risks, with key resistance levels at $37 and $60.

Sep 16, 2026

Schrodinger (SDGR) shares recently surged 12.1% due to investor optimism over the formation of Tectora, a new biotechnology company co-founded by Schrodinger, New Enterprise Associates, and RA Capital Management. Tectora will focus on immunology and inflammation therapies, leveraging Schrodinger's computational platform. Analysts anticipate a quarterly loss of $0.66 per share for Schrodinger, though earnings estimates have been revised upward, suggesting potential for continued stock appreciation.

Sep 13, 2026

This article analyzes Schrodinger Inc. (NASDAQ: SDGR) using AI models, identifying weak near-term sentiment and highlighting a lack of resistance levels above the current price. It outlines three distinct trading strategies (Position, Momentum Breakout, and Risk Hedging) tailored to different risk profiles, along with multi-timeframe signal analysis. The report also notes the company's weak long-term signal strength.